Qualigen Therapeutics (QLGN) Short Interest Ratio & Short Volume $3.71 -0.11 (-2.88%) Closing price 03:59 PM EasternExtended Trading$3.71 0.00 (0.00%) As of 05:23 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Qualigen Therapeutics Short Interest DataQualigen Therapeutics (QLGN) has a short interest of 29,600 shares, representing 4.32% of the float (the number of shares available for trading by the public). This marks a -15.19% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.5, indicating that it would take 0.5 days of the average trading volume of 113,237 shares to cover all short positions.Current Short Interest29,600 sharesPrevious Short Interest34,900 sharesChange Vs. Previous Month-15.19%Dollar Volume Sold Short$112.18 thousandShort Interest Ratio0.5 Days to CoverLast Record DateMay 31, 2025Outstanding Shares736,000 sharesFloat Size685,200 sharesShort Percent of Float4.32%Today's Trading Volume6,381 sharesAverage Trading Volume113,237 sharesToday's Volume Vs. Average6% Short Selling Qualigen Therapeutics? Sign up to receive the latest short interest report for Qualigen Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartQLGN Short Interest Over TimeQLGN Days to Cover Over TimeQLGN Percentage of Float Shorted Over Time Qualigen Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/31/202529,600 shares $112.18 thousand -15.2%4.3%0.5 $3.79 5/15/202534,900 shares $137.51 thousand -21.9%5.1%0.6 $3.94 4/30/202544,700 shares $160.03 thousand -12.9%6.5%0.8 $3.58 4/15/202551,300 shares $168.52 thousand -57.1%7.5%0.6 $3.29 3/31/2025119,500 shares $434.98 thousand +70.5%17.4%1.6 $3.64 3/15/202570,100 shares $214.51 thousand -6.9%10.2%1.6 $3.06 2/28/202575,300 shares $238.70 thousand -15.3%11.0%1.5 $3.17 2/15/202588,900 shares $329.73 thousand -14.4%13.0%1.5 $3.71 1/31/2025103,800 shares $339.43 thousand +49.4%15.2%1.5 $3.27 1/15/202569,500 shares $274.53 thousand -20.4%10.1%0.7 $3.95 Get the Latest News and Ratings for QLGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Qualigen Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/31/202487,300 shares $367.53 thousand -10.7%12.7%0.9 $4.21 12/15/202497,800 shares $378.49 thousand -2.4%14.3%1.1 $3.87 11/30/2024100,200 shares $462.92 thousand +6.1%15.0%1.2 $4.62 11/15/202494,400 shares $339.84 thousand +505.1%14.1%1.1 $3.60 10/31/202415,600 shares $76.91 thousand -85.8%3.1%0.2 $4.93 10/15/2024110,200 shares $17.95 thousand +1.1%0.5%0.2 $0.16 9/30/2024109,000 shares $18.58 thousand -60.5%0.5%0 $0.17 9/15/2024275,600 shares $45.36 thousand -55.1%1.3%0 $0.16 8/31/2024613,400 shares $115.07 thousand +84.4%2.4%0 $0.19 8/15/2024332,600 shares $65.52 thousand +38.8%2.9%0 $0.20 7/31/2024239,600 shares $53.26 thousand -94.2%2.4%0 $0.22 7/15/20244,160,000 shares $1.61 million +627.9%40.9%0.3 $0.39 6/30/2024571,500 shares $98.47 thousand +493.5%6.7%0.1 $0.17 6/15/202496,300 shares $19.16 thousand +20.7%1.6%0.1 $0.20 5/31/202479,800 shares $21.55 thousand +1.7%1.3%0.5 $0.27 5/15/202478,500 shares $24.08 thousand +82.1%1.3%0.8 $0.31 4/30/202443,100 shares $12.92 thousand -12.8%0.8%0.6 $0.30 4/15/202449,400 shares $15.81 thousand -38.2%0.9%0.8 $0.32 3/31/202479,900 shares $31.96 thousand +588.8%1.7%1.3 $0.40 3/15/202411,600 shares $4.29 thousand +11.5%0.3%0.2 $0.37 2/29/202410,400 shares $4.79 thousand -63.5%0.2%0.2 $0.46 2/15/202428,500 shares $13.52 thousand -3.1%0.6%0.7 $0.47 1/31/202429,400 shares $15.45 thousand -14.5%0.6%1.1 $0.53 1/15/202434,400 shares $17.60 thousand +63.8%0.8%1.3 $0.51 12/31/202321,000 shares $11.55 thousand -32.7%0.5%0.9 $0.55 12/15/202331,200 shares $18.03 thousand -8.0%0.7%1.6 $0.58 11/30/202333,900 shares $25.05 thousand -15.9%0.7%2.5 $0.74 11/15/202340,300 shares $28.25 thousand +0.8%0.9%2.7 $0.70 10/31/202340,000 shares $31.11 thousand +5.5%0.9%2.7 $0.78 10/15/202337,900 shares $35.09 thousand -14.5%0.9%1.9 $0.93Everyone’s watching Nvidia right now. Here’s why I’m excited. (Ad)So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.🎯 Click here to watch the video and get the free ticker XGPT just flagged. 9/30/202344,300 shares $44.74 thousand +23.1%1.0%1.7 $1.01 9/15/202336,000 shares $37.80 thousand +77.3%0.8%1.4 $1.05 8/31/202320,300 shares $21.11 thousand -9.8%0.5%0.8 $1.04 8/15/202322,500 shares $24.53 thousand -37.0%0.5%0.9 $1.09 7/31/202335,700 shares $40.34 thousand +28.4%0.8%1.2 $1.13 7/15/202327,800 shares $30.75 thousand -12.3%0.6%1.1 $1.11 6/30/202331,700 shares $28.88 thousand +26.3%0.7%1.1 $0.91 6/15/202325,100 shares $24.10 thousand -38.6%0.6%0.7 $0.96 5/31/202340,900 shares $37.75 thousand +7.4%0.9%0.2 $0.92 5/15/202338,100 shares $38.86 thousand -39.9%0.9%0.2 $1.02 4/30/202363,400 shares $59.51 thousand -5.4%1.5%0.4 $0.94 4/15/202367,000 shares $63.65 thousand -19.2%1.8%0.4 $0.95 3/31/202382,900 shares $76.69 thousand +48.8%2.2%0.2 $0.93 3/15/202355,700 shares $56.26 thousand -31.0%1.5%0.2 $1.01 2/28/202380,700 shares $92.47 thousand +41.6%2.1%0.3 $1.15 2/15/202357,000 shares $70.97 thousand -17.2%1.5%0.2 $1.25 1/31/202368,800 shares $88.75 thousand -61.2%1.8%0.3 $1.29 1/15/2023177,200 shares $237.45 thousand +84.8%4.6%0.8 $1.34 12/30/202295,900 shares $123.62 thousand No Change2.5%0.5 $1.29 12/15/202295,900 shares $136.18 thousand +18.1%2.5%3.7 $1.42 11/30/202281,200 shares $121.60 thousand -11.8%2.1%3.1 $1.50 11/15/202292,100 shares $20.31 thousand -90.0%N/A4.3 $0.22 10/31/2022916,300 shares $201.59 thousand -2.7%N/A4.3 $0.22 10/15/2022941,700 shares $253.13 thousand -15.9%N/A4 $0.27 9/30/20221,120,000 shares $299.04 thousand +25.5%N/A4.7 $0.27 9/15/2022892,200 shares $291.93 thousand -11.7%N/A3.6 $0.33 8/31/20221,010,000 shares $384.41 thousand -1.0%N/A4.3 $0.38 8/15/20221,020,000 shares $433.50 thousand -8.9%N/A4.5 $0.43 7/31/20221,120,000 shares $469.06 thousand -2.6%N/A4.8 $0.42 7/15/20221,150,000 shares $535.67 thousand -2.5%N/A5.1 $0.47 6/30/20221,180,000 shares $672.25 thousand -9.9%N/A1 $0.57 6/15/20221,310,000 shares $793.47 thousand -9.0%N/A1.2 $0.61 5/31/20221,440,000 shares $807.84 thousand +2.1%N/A1.3 $0.56 5/15/20221,410,000 shares $751.53 thousand +13.7%N/A1.2 $0.53 4/30/20221,240,000 shares $706.80 thousand -43.9%N/A1.1 $0.57 4/15/20222,210,000 shares $1.60 million +63.7%N/A1.8 $0.73 3/31/20221,350,000 shares $891 thousand +3.9%N/A3.9 $0.66 3/15/20221,300,000 shares $741.00 thousand -3.7%N/A0.7 $0.57 2/28/20221,350,000 shares $891 thousand +2.3%N/A0.6 $0.66 2/15/20221,320,000 shares $970.86 thousand -7.0%N/A0.2 $0.74 1/31/20221,420,000 shares $1.24 million -7.8%N/A0.2 $0.87 1/15/20221,540,000 shares $1.62 million -36.1%5.8%0.2 $1.05 12/31/20212,410,000 shares $2.58 million +33.9%9.3%0.3 $1.07 12/15/20211,800,000 shares $1.74 million -68.4%6.9%0.2 $0.96 11/30/20215,700,000 shares $8.38 million +258.5%22.1%0.8 $1.47 11/15/20211,590,000 shares $1.70 million -7.0%6.2%0.3 $1.07 10/29/20211,710,000 shares $1.97 million +4.3%6.7%3.8 $1.15 10/15/20211,640,000 shares $1.92 million -0.6%6.4%3.7 $1.17 9/30/20211,650,000 shares $2.15 million -0.6%6.4%3.5 $1.30 9/15/20211,660,000 shares $2.39 million +16.9%6.5%3.3 $1.44Everyone’s watching Nvidia right now. Here’s why I’m excited. (Ad)So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.🎯 Click here to watch the video and get the free ticker XGPT just flagged. 8/31/20211,420,000 shares $2.23 million -18.9%5.5%2.7 $1.57 8/13/20211,750,000 shares $3.12 million -1.1%6.8%5.2 $1.78 7/30/20211,770,000 shares $3.13 million +2.3%6.9%5 $1.77 7/15/20211,730,000 shares $2.92 million +4.2%6.8%3.4 $1.69 6/30/20211,660,000 shares $3.30 million +9.2%6.5%2.7 $1.99 6/15/20211,520,000 shares $3.19 million -16.0%6.0%2.3 $2.10 5/28/20211,810,000 shares $3.46 million +0.6%7.1%2.5 $1.91 5/14/20211,800,000 shares $2.75 million -6.3%7.1%2.1 $1.53 4/30/20211,920,000 shares $4.22 million +7.9%7.5%1.6 $2.20 4/15/20211,780,000 shares $3.65 million No Change6.3%1.1 $2.05 3/31/20211,780,000 shares $4.63 million -11.4%6.2%1.1 $2.60 3/15/20212,010,000 shares $6.69 million +24.8%7.6%1.2 $3.33 2/26/20211,610,000 shares $5.47 million -10.6%6.1%0.8 $3.40 2/12/20211,800,000 shares $6.98 million -9.6%6.8%1 $3.88 1/29/20211,990,000 shares $7.12 million +3.7%7.5%1.2 $3.58 1/15/20211,920,000 shares $6.62 million No Change7.3%1.5 $3.45 QLGN Short Interest - Frequently Asked Questions What is Qualigen Therapeutics' current short interest? Short interest is the volume of Qualigen Therapeutics shares that have been sold short but have not yet been closed out or covered. As of May 31st, investors have sold 29,600 shares of QLGN short. 4.32% of Qualigen Therapeutics' shares are currently sold short. Learn More on Qualigen Therapeutics' current short interest. What is a good short interest percentage for Qualigen Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.32% of Qualigen Therapeutics' floating shares are currently sold short. Is Qualigen Therapeutics' short interest increasing or decreasing? Qualigen Therapeutics saw a decline in short interest in the month of May. As of May 31st, there was short interest totaling 29,600 shares, a decline of 15.2% from the previous total of 34,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Qualigen Therapeutics' float size? Qualigen Therapeutics currently has issued a total of 736,000 shares. Some of Qualigen Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Qualigen Therapeutics currently has a public float of 685,200 shares. How does Qualigen Therapeutics' short interest compare to its competitors? 4.32% of Qualigen Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Qualigen Therapeutics: Bright Green Co. (0.04%), Calidi Biotherapeutics, Inc. (0.99%), Athira Pharma, Inc. (2.66%), Aytu BioPharma, Inc. (6.96%), Hoth Therapeutics, Inc. (0.43%), Minerva Neurosciences, Inc. (0.59%), HCW Biologics Inc. (3.51%), Lakeshore Biopharma Co., Ltd. (0.12%), Aprea Therapeutics, Inc. (1.53%), Phio Pharmaceuticals Corp. (4.79%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($64.96 billion), Invesco QQQ ($27.88 billion), iShares Russell 2000 ETF ($19.94 billion), iShares 20+ Year Treasury Bond ETF ($9.69 billion), Strategy Incorporated ($8.58 billion), SPDR S&P Biotech ETF ($5.72 billion), Invesco S&P 500 Equal Weight ETF ($5.45 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.70 billion), Charter Communications, Inc. ($4.54 billion), and Industrial Select Sector SPDR Fund ($4.49 billion). View all of the most shorted stocks. What does it mean to sell short Qualigen Therapeutics stock? Short selling QLGN is an investing strategy that aims to generate trading profit from Qualigen Therapeutics as its price is falling. QLGN shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Qualigen Therapeutics? A short squeeze for Qualigen Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of QLGN, which in turn drives the price of the stock up even further. How often is Qualigen Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including QLGN, twice per month. The most recent reporting period available is May, 31 2025. More Short Interest Resources from MarketBeat Related Companies Bright Green Short Interest Data Calidi Biotherapeutics Short Interest Data Athira Pharma Short Interest Data Aytu BioPharma Short Interest Data Hoth Therapeutics Short Interest Data Minerva Neurosciences Short Interest Data HCW Biologics Short Interest Data Lakeshore Biopharma Short Interest Data Aprea Therapeutics Short Interest Data Phio Pharmaceuticals Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:QLGN) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredTrump’s true trade war strategyThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Qualigen Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Qualigen Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy QLGN Stock Free QLGN Stock Alerts